Back
The Joint Corp. (United States) Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
37
JYNT
The Joint Corp. (United States)
Last Price:
$8.96
Seasonality Move:
14.26%
Buy
75
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Sell
37
The Joint Corp. (United States) (JYNT)
is a Sell
Is The Joint Corp. (United States) a Buy, Sell or Hold?
-
The current The Joint Corp. (United States) [JYNT] share price is $8.83. The Score for JYNT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
JYNT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JYNT Stock Price Chart
What is The Joint Corp. (United States)'s stock price today?
-
The The Joint Corp. (United States) share price today is $8.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JYNT is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $95.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
JYNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 52.93 | Buy |
| Chaikin Money Flow: | -2938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.52 - 8.96) | Buy |
| Bollinger Bands (100): | (8.17 - 10.09) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.7 | Buy |
| Relative Strength Index (14 RSI): | 65.61 | Buy |
| Chaikin Money Flow: | 292843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.33 - 88.51) | Buy |
| Bollinger Bands (100): | (45.68 - 74.86) | Buy |
JYNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.83 | Buy |
| 20-day SMA: | 8.83 | Sell |
| 50-day SMA: | 8.46 | Buy |
| 200-day SMA: | 10.1 | Sell |
| 8-day EMA: | 8.85 | Sell |
| 20-day EMA: | 8.78 | Buy |
| 50-day EMA: | 8.76 | Buy |
| 200-day EMA: | 9.8 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.5 | Buy |
| 20-day SMA: | 83.91 | Buy |
| 50-day SMA: | 69.69 | Buy |
| 200-day SMA: | 45.45 | Buy |
| 8-day EMA: | 85.95 | Buy |
| 20-day EMA: | 81.76 | Buy |
| 50-day EMA: | 72.81 | Buy |
| 200-day EMA: | 51.04 | Buy |
The Joint Corp. (United States) Earnings Growth & JYNT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.05 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.
The Joint Corp. (United States) Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||